Announcements Trials
Browse Landscape

Phase

Phase 2 24Phase 1 7Phase NA 6Phase 1/2 3Phase EARLY_PHASE1 1Phase 4 1Phase 3 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Multiple Myeloma 3Neoplasms, Neuroepithelial 1Lymphoma, T-Cell 1Lymphoma, B-Cell 1Leukemia, T-Cell 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 5fludarabine 3pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1fiu protein, E coli 1Vincristine 1Surveys and Questionnaires 1Sugars 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Methotrexate 1Melphalan 1Loratadine 1Etoposide 1Doxorubicin 1Cholestanetriol 26-Monooxygenase 1CVAD protocol 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Burkitt Lymphoma × Melphalan × Clear all
NCT04264039 2020-02-11

Anti-CD19 U-CAR-T Cell Therapy for B Cell Hematologic Malignancies

Xinqiao Hospital of Chongqing

Phase EARLY_PHASE1 Unknown
30 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡